Clinical trial
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid…
NCT00413699 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00413699 |
|---|---|
| Title | Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis |
| Official title | A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Arthritis, Rheumatoid |
| Intervention type | Drug |
| Interventions | CP-690, 550 |
| Enrollment | 4,488 |
| Start date | Feb 5, 2007 |
| Primary completion | Nov 30, 2016 |
| Completion | Oct 26, 2017 |
| First posted | Dec 20, 2006 |
| Last update posted | Oct 30, 2018 |
| Countries | Argentina, Australia, Austria, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica and 31 more |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: